Ortega FLM, Álvarez PAB, Águila NY, Viera HMI

Language: Spanish
References: 12
Page:
PDF size: 111.5 Kb.

ABSTRACT

Introduction: the pre-term labor is produced before the 37 weeks of pregnancy; the vaginal sepsis is one of the predisposing risk factors to it, being a motive of worry for obstetricians and neonatologists.
Objective: to assess the use of Test Mycoplasma System Plus in pregnancies with risk of pre-term labor, as well as of its clinical features.
Methods: a descriptive and retrospective study was conducted from January to September, 2010 in the "Profesor Eusebio Hernández Hospital; sample included 88 patients admitted in the perinatal special care unit with pregnancies under 34 weeks and performing of test who gave birth in this institution; data were collected from the medical records and microbiology reports grouped in a form and processed by descriptive statistics and of frequency distribution.
Results: the 6l7 % of patients had a moderate or severe infection due to ureaplasma where as the vaginal exudates were negatives in the 71.5 %, the more used antimicrobial agents was the erythromycin.
Conclusions: most of patients after an appropriate treatment arrive to a term pregnancy and also had negative simple vaginal exudate but with a high rate of infection due to ureaplasma urelyticum.

REFERENCES

1. Hapsari ED, Hayashi M, Matsuo H. Clinical characteristic of vaginal discharge in bacterial vaginosis diagnosed by Nugent´s criteria. Clin Exp Obstet Gynecol Clin. 2006;33:5-9.

2. Muñoz Zurita G, Sánchez Hernández J, Mendoza López E. Incidencia de Flora cocoide en muestras cérvico-vaginales en pacientes atendidas en el Departamento de Biología Celular FMBUAP del 2000 al 2007. Acta Cient Estud. 2009;7(3):184-90.

3. Klebanoff MA, Schwebke JR, Zhang J. Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004;104:267.

4. Ortiz Rodríguez C, Ley M. Vaginosis bacteriana en mujeres con leucorrea. Rev Cubana Obstet Ginecol. 2000;26(2):56-8.

5. Vaginosis bacteriana. [simposio]. Rev Peruana de Ginecología y Obstetricia. 2007;53(3):168-71.

6. Jesús de la Calle I, Jesús de la Calle MA. Vaginosis bacteriana. Medicina clínica. 2009;133(20):789-97.

7. Rojas JT, Ramírez J. Prevalencia de Vaginosis Bacteriana en el embarazo. UNMSM. Ginecol obstet. 2004;50(2):101-5.

8. Horowitz S, Mazor M, Horowitz J, Porath A, Glezerman M.. Antibodies to Ureaplasma urealyticum in women with intraamniotic infection and adverse pregnancy outcome. Acta Obstet Gynecol Scand. 1995;74:132-6.

9. Waites KB, Katz B, Schelonka RL. Mycoplasma and Ureaplasmas as Neonatal Pathogens. Clin Microbiol Rev. 2005 October;18(4):757-89.

10. Raynes-Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL. Antibióticos para el tratamiento de la infección vaginal por ureaplasma en el embarazo (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com/BCP/BCPGetDocument.asp?DocumentID=CD003767

11. McDonald H. Preterm labor. In: Elder MG, Romero R, Lamont RF, (editors). 1st Edition. New York: Churchill Livingstone; 1997. p. 65-83.

12. Abele-Horn M, Scholz M, Wolff C, Kolben M. High-density vaginal ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery. Acta Obstetric Gynecological Scandinavia. 2000;79(11):973-8.